Anti-(homo Sapiens Cd47 (integrin Associated Protein

Anti-(homo Sapiens Cd47 (integrin Associated Protein Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-(homo Sapiens Cd47 (integrin Associated Protein is under investigation in clinical trial NCT02953782 (Trial of Anti-(homo Sapiens Cd47 (integrin Associated Protein (Hu5f9-g4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer).

Trade Name Anti-(homo Sapiens Cd47 (integrin Associated Protein
Generic Magrolimab
Magrolimab Other Names Anti-cd47 monoclonal antibody hu5f9-g4, Immunoglobulin g4-kappa, anti-(homo sapiens cd47 (integrin associated protein, iap, mer6, oa3)), monoclonal antibodygamma4 heavy chain (1-444) (vh (homo sapiens ighv1-3*01 (87.8%)-(ighd)-ighj4*01 (100%)) (8.8.10) (1-117)-homo sapiens ighg4*01 (ch1 (118-2, Immunoglobulin g4(225-proline), anti-(human cd47 antigen) (human-mus musculus monoclonal hu5f9-g4 .gamma.4-chain), disulfide with human-mus musculus monoclonal hu5f9-g4 .kappa.-chain, dimer, Magrolimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Anti-(homo Sapiens Cd47 (integrin Associated Protein
Anti-(homo Sapiens Cd47 (integrin Associated Protein

Innovators Monograph

You find simplified version here Anti-(homo Sapiens Cd47 (integrin Associated Protein


*** Taking medicines without doctor's advice can cause long-term problems.
Share